(Q45076857)

9 December 2017

title

Mycophenolate mofetil monotherapy in liver transplant recipients (English)

1 reference

9 December 2017

Michael Kriss

1

1 reference

9 December 2017

Eva U Sotil

2

1 reference

9 December 2017

Michael Abecassis

3

1 reference

9 December 2017

Mary Welti

4

1 reference

9 December 2017

Josh Levitsky

5

1 reference

9 December 2017

publication date

18 October 2011

1 reference

9 December 2017

published in

Clinical Transplantation

1 reference

9 December 2017

volume

25

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

E639-46

1 reference

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Kidney dysfunction in the recipients of liver transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Calcineurin inhibitor minimization protocols in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil monotherapy in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil can be used as monotherapy late after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Efficacy and safety of mycophenolate mofetil monotherapy in liver transplant patients with renal failure induced by calcineurin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Mycophenolate mofetil monotherapy in patients who underwent liver transplantation for hepatitis C cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

A clinical assessment of mycophenolate drug monitoring after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2011.01512.X

10.1111/J.1399-0012.2011.01512.X

21 January 2018

Identifiers

DOI

1 reference

release_cc73hlzs6na6jhzrv6tsgqlp3m

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cc73hlzs6na6jhzrv6tsgqlp3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference